The question whether maternal spindle transfer (MST) and pronuclear transfer (PNT) can be prohibited under EU legislation was examined by the non-governmental organisation European Bioethics Research (EBR). It did so by submitting an official complaint to the EU Commission proposing that the UK Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 breached the prohibition on the modification of a person’s germ line genetic identity of the EU Clinical Trials Directive 2001/20/EC and the new Regulation EU 536/2014. A discussion then took place, during 2016, between EBR and the EU Commission whether MST and PNT principally involved a ‘medicinal product’ in which case the EU Clinical Trials Directive 2001/20/EC and Regulation EU 536/2014 would be applicable or whether the procedures just involved a medical procedure in which case the Tissue and Cells Directive 2004/23/EC was applicable which did not include any prohibition on the intentional modification of a person’s germline.

中文翻译：

---

欧盟立法是否可以禁止母体主轴转让和原核转让？

非政府组织欧洲生物伦理研究（EBR）审查了根据欧盟法律是否可以禁止母体纺锤体转移（MST）和核前体转移（PNT）的问题。为此，它向欧盟委员会提交了一份正式申诉，提议《 2015年英国人类受精和胚胎学（线粒体捐赠）条例》违反了欧盟临床试验指令2001/20 / EC禁止修改人种系遗传特性的规定。以及新的欧盟法规536/2014。然后在2016年进行了讨论，